Emerging PAD Devices Impress With New Trial Results, Funding

Two very different ways to treat peripheral arterial disease – lithotripsy combined with angioplasty and nitinol Tack implants – have demonstrated impressive six-month and one-year clinical results, respectively, and companies with these devices continue to attract funding.

Treating peripheral arterial disease (PAD) with novel devices not only reveals good clinical outcomes, but continues to attract the investment community.

Six-month results of DISRUPT PAD, a 35-patient study of Shockwave Medical Inc.’s Lithoplasty balloon catheter, were presented in April...

More from Strategy

More from Business